NCT00685464View on ClinicalTrials.gov

Intravenous Versus Intracoronary Use of Abciximab

NACompletedINTERVENTIONAL
Enrollment

355

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2009

Conditions
AtherosclerosisIschemic Heart Disease
Interventions
DRUG

Abciximab

Intravenous.

DRUG

Abciximab

Intracoronary

Trial Locations (1)

2900

Dept. of Cardiology, Gentofte University Hospital, Hellerup

All Listed Sponsors
lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT00685464 - Intravenous Versus Intracoronary Use of Abciximab | Biotech Hunter | Biotech Hunter